TopFunds

Align Technology

NASDAQ: ALGN

Stock price

141.03 USD

(+0%) TODAY

Health Care SuppliesMedical - Devices
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
1.8
2.3
2.8
4.9
5.5
22.4
9.7
4.6
5.8
5.6
5.7
12.3%
02Free cash flow per share
2.3
2.2
3
4.1
7.5
6.4
9.7
3.5
7.9
8.3
6.8
11.6%
03Dividends per share
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
PROFIT AND LOSS STATEMENT
05Revenue
845.5
1,080
1,473
1,967
2,407
2,472
3,953
3,735
3,862
3,999
4,035
16.9%
06% Change
-
-
-
-
-
-
-
-
-
-
-
16.9%
07Cost of revenue
(205.4)
(264.6)
(356.5)
(518.6)
(662.9)
(708.7)
(1,017)
(1,101)
(1,155)
(1,200)
(1,278)
20.1%
08Gross profit
640.1
815.3
1,117
1,448
1,744
1,763
2,935
2,634
2,707
2,799
2,757
15.7%
09% Margin
75.7%
75.5%
75.8%
73.6%
72.5%
71.3%
74.3%
70.5%
70.1%
70%
68.3%
72.5% A
10Operating expenses
(451.5)
(566.4)
(763.3)
(981.3)
(1,201)
(1,376)
(1,959)
(1,991)
(2,064)
(2,192)
(2,141)
16.8%
11% of Revenue
(53.4)%
(52.5)%
(51.8)%
(49.9)%
(49.9)%
(55.7)%
(49.6)%
(53.3)%
(53.4)%
(54.8)%
(53.1)%
(52.5)% A
12Operating Income
188.6
248.9
353.6
466.6
542.5
387.2
976.4
642.6
643.3
607.6
616.2
12.6%
13Income tax expense
(42.1)
(51.2)
(130.2)
(57.7)
(112.3)
(1,397)
(240.4)
(237.5)
(196.2)
(187.6)
(174.9)
15.3%
14Net Income
144
189.7
231.4
400.2
442.8
1,776
772
361.6
445.1
421.4
410.4
11%
15% Margin
17%
17.6%
15.7%
20.4%
18.4%
71.8%
19.5%
9.7%
11.5%
10.5%
10.2%
20.2% A
16Shares Outstanding
81.5
81.5
81.8
81.4
80.1
79.2
79.7
78.4
76.6
75
72.6
(1.2)%
17EPS Basic
1.8
2.4
2.9
5
5.6
22.6
9.8
4.6
5.8
5.6
5.7
12.1%
18EPS Diluted
1.8
2.3
2.8
4.9
5.5
22.4
9.7
4.6
5.8
5.6
5.7
12.3%
19EBITDA
206.6
272.9
391.4
521.3
593.5
480.7
1,121
779.8
799.1
816.8
765.9
14%
% Margin
24.4%
25.3%
26.6%
26.5%
24.7%
19.5%
28.4%
20.9%
20.7%
20.4%
19%
23.3% A
20Net Interest Income (expense)
(2.5)
4.2
6.9
8.6
12.5
3.1
3.1
5.4
17.3
20.2
16
-
21Net Debt / EBITDA
(0.8)
(1.4)
(1.1)
(1.2)
(0.8)
(1.8)
(0.9)
(1)
(1)
(1.1)
(1.3)
(1.1) A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
167.7
389.3
449.5
636.9
550.4
960.8
1,099
942.1
937.4
1,044
1,079
20.5%
23Short-term investments
359.6
251
272
98.5
318.2
-
72
57.5
35.3
-
15.9
(26.8)%
24Accounts receivable
158.6
247.4
324.2
482.3
616.5
657.7
990.8
1,000
1,047
1,030
1,158
22%
25Other current assets
26.7
38.2
80.9
29.2
36.2
91.8
101.7
85.9
129.8
164.6
137.7
17.8%
26Inventory
19.5
27.1
31.7
55.6
112.1
139.2
230.2
338.8
296.9
254.3
226.3
27.8%
27Total Current Assets
732
953
1,157
1,303
1,633
1,850
2,494
2,424
2,447
2,492
2,617
13.6%
Non-Current Assets
28Net property, plant & equipment
136.5
175.2
348.8
521.3
688
817.3
1,203
1,351
1,409
1,385
1,240
24.7%
29Long-term investments
151.4
104.8
94.6
64.9
5.9
-
125.3
42
8
-
-
(30.7)%
30Other non-current assets
138.8
163.2
177.5
163.8
173.4
2,163
2,120
2,131
2,220
2,338
2,377
32.9%
31Total Non-Current Assets
426.6
443.2
620.9
750
867.3
2,980
3,448
3,524
3,637
3,722
3,617
23.8%
Total Assets
1,159
1,396
1,778
2,053
2,501
4,830
5,942
5,948
6,084
6,215
6,234
18.3%
LIABILITIES
Current Liabilities
32Accounts payable
34.4
28.6
36.8
64.3
87.3
142.1
163.9
127.9
113.1
108.7
121.5
13.5%
33Short-term debt
-
-
-
-
15.7
21.7
22.7
26.6
29.7
31.1
31.9
12.5%
34Other current liabilities
237.3
325.7
461
627.8
868
1,162
1,738
1,771
1,924
1,898
1,767
22.2%
35Total Current Liabilities
271.7
354.3
497.8
692.1
971
1,326
1,924
1,926
2,067
2,038
1,920
21.6%
Non-Current Liabilities
36Long-term debt
-
-
-
-
43.5
64.4
102.7
100.3
97
88.2
82.5
11.3%
37Other non-current liabilities
39
46.4
129.7
107.5
140.1
205.8
292.7
320.4
289.8
236.4
182
16.7%
38Total Non-Current Liabilities
39
46.4
129.7
107.5
183.6
270.2
395.3
420.7
386.8
324.6
264.5
21.1%
39Total Liabilities
310.7
400.8
627.5
799.6
1,155
1,596
2,319
2,347
2,453
2,363
2,185
21.5%
SHAREHOLDERS` EQUITY
40Common stock
-
-
-
-
-
-
-
-
-
-
-
(1.3)%
41Retained earnings / (deficit)
27.4
131.4
263.4
378.1
439.9
2,216
2,619
2,567
2,447
2,484
2,464
56.8%
42Accumulated other comprehensive income / (loss)
(1)
(0.9)
0.6
(2.8)
(0.7)
43.5
4.3
(10.3)
21.2
6
75.4
-
43Noncontrolling interests
-
-
-
-
-
-
-
-
-
-
-
-
44Total shareholders' equity
847.9
995.4
1,150
1,253
1,346
3,234
3,623
3,601
3,631
3,852
4,049
16.9%
45Total Liabilities and shareholders' Equity
1,159
1,396
1,778
2,053
2,501
4,830
5,942
5,948
6,084
6,215
6,234
18.3%
46Total Debt
-
-
-
-
59.2
86.2
125.4
126.9
126.6
119.3
114.4
11.6%
47Net Debt
(167.7)
(389.3)
(449.5)
(636.9)
(491.2)
(874.7)
(974)
(815.1)
(810.8)
(924.6)
(964.5)
19.1%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
144
189.7
231.4
400.2
442.8
1,776
772
361.6
445.1
421.4
410.4
11%
49Depreciation & amortization
18
24
37.7
54.7
79
93.5
108.7
125.8
142.4
145
237.4
29.4%
50Share-based compensation expense
52.9
54.1
58.9
70.8
88.2
98.4
114.3
133.4
154
173.7
185.9
13.4%
51Changes in working capital and other assets
23
(20.2)
110.5
29
137.3
(1,306)
177.5
(52)
44.3
(1.9)
(240.4)
-
52Net cash flows from operating activities
238
247.7
438.5
554.7
747.3
662.2
1,173
568.7
785.8
738.2
593.2
9.6%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(53.5)
(70.6)
(195.7)
(223.3)
(149.7)
(154.9)
(401.1)
(291.9)
(177.7)
(115.6)
(102.4)
6.7%
54Purchases of investments / marketable securities
(447.1)
(405.6)
(390.2)
(180.2)
(693.3)
(5.3)
(200.9)
(28)
(2.9)
-
(10)
(31.6)%
55Proceeds from maturities of marketable securities
334.1
604
388.8
384.7
485.4
321.5
47
121.1
61.4
43.9
-
(20.2)%
56Other investing activities
-
(55)
(51.1)
25.8
7.1
(392.7)
(8.4)
(14.5)
(76.7)
(183.2)
-
-
57Net cash flows from investing activities
(166.4)
72.8
(248.3)
6.9
(350.4)
(231.5)
(563.4)
(213.3)
(195.9)
(254.9)
(112.4)
(3.8)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(90.5)
(82.4)
(89.3)
(283.4)
(382.1)
20.3
(349.4)
(408.9)
(565.8)
(327.6)
(444.2)
17.3%
59Dividends paid, net
-
-
-
-
-
-
-
-
-
-
-
-
60Debt issuance (repayments), net
-
-
-
-
(45.8)
-
-
-
-
-
-
-
61Other financing activities
(10.3)
(13.1)
(46.2)
(86.1)
(57.7)
(51.1)
(108.9)
(92.8)
(32.6)
(28.1)
(20.4)
7.1%
62Net cash flows from financing activities
(100.8)
(95.5)
(135.5)
(369.4)
(485.5)
(30.8)
(458.3)
(501.7)
(598.3)
(355.7)
(464.6)
16.5%
63Increase (decrease) in cash and cash equivalents
(32.2)
221.6
60.2
187.4
(86.4)
410.3
138.7
(157.8)
(3.8)
106.4
51.2
-
64Cash and equivalents, ending balance
167.7
389.3
449.5
637.6
551.1
961.5
1,100
942.4
938.5
1,045
1,096
20.7%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
184.5
177.1
242.8
331.4
597.6
507.3
771.4
276.8
608.1
622.7
490.8
10.3%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Align Technology (ALGN) financial statements and performance

Explore Align Technology (ALGN) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.